Heparin induces dimerization and confers proliferative activity onto the hepatocyte growth factor antagonists NK1 and NK2

Journal of Cell Biology

Volumn 133, Issue 3, 1996, Pages 709-718

  Schwall, Ralph H ^a   Chang, Ling Y ^a   Godowski, Paul J ^a   Kahn, David W ^a   Hillan, Kenneth J ^a   Bauer, Kenneth D ^a   Zioncheck, Thomas F ^a  

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HEPARIN; HEPATOCYTE GROWTH FACTOR ANTAGONIST; INTERLEUKIN 3; MITOGENIC AGENT; NK 1; NK 2; PROTEOHEPARAN SULFATE; SCATTER FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; COMPETITIVE INHIBITION; CONTROLLED STUDY; DIMERIZATION; DNA SYNTHESIS; FEMALE; LIVER CELL; LUNG ALVEOLUS CELL; MINK; NONHUMAN; PRIORITY JOURNAL; PROTO ONCOGENE; RAT;

ANIMALS; CELL DIVISION; DNA; FEMALE; GLYCOSAMINOGLYCANS; HEPARIN; HEPATOCYTE GROWTH FACTOR; HUMANS; LIVER; LUNG; MINK; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-MET; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, NEUROKININ-1; RECEPTORS, NEUROKININ-2; SENSITIVITY AND SPECIFICITY;

EID: 0029897025     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.133.3.709     Document Type: Article

References (41)

1. Aviezer, D., and A. Yayon. 1994. Heparin-dependent binding and autophosphorylation of epidermal growth factor (EGF) receptor by heparin-binding EGF-like growth factor but not by EGF. Proc. Natl. Acad. Sci. USA. 91:12173-12177.
2. Bottaro, D.P., J.S. Rubin, D.L. Faletto, A.M. Chan, T.E. Kmiecik, G.F. Vande Woude, and S.A. Aaronson. 1991. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science (Wash. DC). 251:802-804.
3. Chan, A.M., J.S. Rubin, D.P. Bottaro, D.W. Hirschfield, M. Chedid, and S.A. Aaronson. 1991. Identification of a competitive HGF antagonist encoded by an alternative transcript. Science (Wash. DC). 254:1382-1385.
4. Di Renzo, M.F., R.P. Narsimhan, M. Olivero, S. Bretli, S. Giordano, E. Medico, P. Gaglia, P. Zara, and P.M. Comoglio. 1991. Expression of the Met/HGF receptor in normal and neoplastic human tissues. Oncogene. 6: 1997-2003.
5. Di Renzo, M.F., M. Olivero, G. Serini, F. Orlandi, S. Pilotli, A. Belfiore, A. Costantino, R. Vigneri, A. Angeli, M.A. Pierotti et al. 1995. Overexpression of the c-MET/HGF receptor in human thyroid carcinomas derived from the follicular epithelium. J. Endocrinol. Invest. 18:134-139.
6. Ebert, M., M. Yokoyama, H. Friess, M.W. Büchler, and M. Korc. 1994. Coexpression of the c-met proto-oncogene and hepatocyte growth factor in human pancreatic cancer. Cancer Res. 54:5775-5778.
7. Garrison, J.C., and R.C. Haynes, Jr. 1975. The hormonal control of gluconeogenesis by regulation of mitochondrial pyruvate carboxylation in isolated rat liver cells. J Biol. Chem. 250:2769-2777.
8. Gherardi, E., and M. Stoker. 1991. Hepatocyte growth factor-Scatter factor: mitogen, motogen and met. Cancer Cells A Mon. Rev. 3:227-232.
9. Giordano, S., M.F. Di Renzo, R. Narsimhan, C.S. Cooper, C. Rosa, and P. Comoglio. 1989. Biosynthesis of the protein encoded by the c-met protooncogene. Oncogene. 4:1383-1388.
10. Hartmann, G., L. Naldini, K.M. Weidner, M. Sachs, E. Vigna, P.M. Comoglio, and W. Birchmeier. 1992. A functional domain in the heavy chain of scatter factor/hepatocyte growth factor binds the c-Met receptor and induces cell dissociation but not mitogenesis. Proc. Natl. Acad. Sci. USA. 89:11574-11578.
11. Higashio, K., N. Shima, M. Goto, Y. Itagaki, M. Nagao, H. Yasuda, and T. Morinaga. 1990. Identity of a tumor cytotoxic factor from human fibroblasts and hepatocyte growth factor. Biochem. Bitiphvs. Res. Commun. 170:397-404.
12. Jackson, R.L., S.J. Busch, and A.D. Cardin. 1991. Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes. Physiol. Rev. 71:481-539.
13. Klagsbrun, J., and A. Baird. 1991. A dual receptor system is required for basic fibroblast growth factor activity. Cell. 67:229-231.
14. Kobayashi, T., K. Honke, T. Miyazaki, K. Matsumoto, T. Nakamura, I. Ishizuka, and A. Makita. 1994. Hepatocyte growth factor specifically binds to sulfoglycolipids. J. Biol. Chem. 269:9817-9821.
15. Kuniyasu, H., W. Yasui, H. Yokozaki, Y. Kitadai, and E. Tahara. 1993. Aberrant expression of c-met mRNA in human gastric carcinomas. Int. J. Cancer. 55:72-75.
16. Lokker, N.A., and P.J. Godowski. 1993. Generation and characterization of a competitive antagonist of human hepatocyte growth factor, HGF/ NK1. J. Biol Chem. 268:17145-17150.
17. Matsumoto, K., and T. Nakamura. 1992. Hepatocyte growth factor: molec ular structure, roles in liver regeneration, and other biological functions. Crit. Rev. Oncog. 3:27-54.
18. Miyazawa, K., A. Kitamura, D. Naka, and N. Kitamura. 1991. An alternatively processed mRNA generated from human hepatocyte growth factor gene. Eur. J. Biochem. 197:15-22.
19. Mizuno, K., H. Inoue, M. Hagiya, S. Shimizu, T. Nose, Y. Shimohigashi, and T. Nakamura. 1994. Hairpin loop and second kringle domain are essential sites for heparin binding and biological activity of hepatocyte growth factor. J. Biol. Chem. 269:1131-1136.
20. Montesano, R., K. Matsumoto, T. Nakamura, and L. Orci. 1991. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell. 67:901-908.
21. Nakamura, T. 1991. Structure and function of hepatocyte growth factor. Prog. Growth Factor Res. 3:67-86.
22. Naldini, L., E. Vigna, R.P. Narsimhan, G. Gaudino, R. Zarnegar, G.K. Michalopoulos, and P.M. Comoglio. 1991. Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET. Oncogrne. 6:501-504,
23. Naldini, L., K.M. Weidner, E. Vigna, G. Gaudino, A. Bardelli, C. Ponzetto, R.P. Narsimhan, G. Hartmann, R. Zarnegar, G.K. Michalopoulos et al. 1991. Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor. EMBO (Eur. Mol. Biol. Organ.) J. 10: 2867-2878.
24. Natali, P.G., M.R. Nicotra, M.F. Di Renzo, M. Prat, A. Bigolti, R. Cavaliere, and P.M. Comoglio. 1993. Expression of the c-Met/HGF receptor in human melanocytic neoplasms: demonstration of the relationship to malignant melanoma tumour progression. Br. J. Cancer. 68:746-750.
25. Ornitz, D.M., A. Yayon, J.G. Flanagan, C.M. Svahn, E. Levi, and P. Leder. 1992. Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. Mol. Cell. Biol. 12:240-247.
26. Rapraeger, A.C., A. Krufka, and B.B. Olwin. 1991. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science (Wash. DC). 252:1705-1708.
27. Roghani, M., A. Mansukhani, P. Dell'Era, P. Bellosta, C. Basilico, D.B. Rifkin, and D. Moscatelli. 1994. Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding. J. Biol. Chem. 269:3976-3984.
28. Rong, S., M. Bodescot, D. Blair, J. Dunn, T. Nakamura, K. Mizuno, M. Park, A. Chan, S. Aaronson, and G.F. Vande Woude. 1992. Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor. Mol. Cell. Biol. 12:5152-5158.
29. Rong, S., M. Jeffers, J.H. Resau, I. Tsarfaty, M. Oskarsson, and G.F. Vande Woude. 1993. Met expression and sarcoma tumorigenicity. Cancer Res. 53:5355-5360.
30. Rong, S., L.A. Donehower, M.F. Hansen, L. Strong, M. Tainsky, M. Jeffers, J.H. Resau, E. Hudson, I. Tsarfaty, and G.F. Vande Woude. 1995. Met proto-oncogene product is overexpressed in tumors of p53-deficient mice and tumors of Li-Fraumeni patients. Cancer Res. 55:1963-1970.
31. Rosen, E.M., S.K. Nigam, and I.D. Goldberg. 1994. Scatter factor and the c-met receptor: a paradigm for mesenchymal/epithelial interaction. J. Cell Biol. 127:1783-1787.
32. Rouslahti, E., and Y. Yamaguchi. 1991. Proteoglycans as modulators of growth factor activities. Cell. 64:867-869.
33. Sasaki, M., M. Nishio, T. Sasaki, and J. Enami. 1994. Identification of mouse mammary fibroblast-derived mammary growth factor as hepatocyte growth factor. Biochem. Biophys. Res. Commun. 199:772-779.
34. Sonnenberg, E., D. Meyer, K.M. Weidner, and C. Birchmeier. 1993. Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development. J. Cell Biol. 123:223-235.
35. Stoker, M. 1989. Effect of scatter factor on motility of epithelial cells and fibroblasts. J. Cell. Physiol. 139:565-569.
36. Weidner, K.M., J. Behrens, J. Vandekerckhove, and W. Birchmeier. 1990. Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells. J. Cell Biol. 111:2097-2108.
37. Weidner, K.M., M. Sachs, and W. Birchmeier. 1993. The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/hepatocyle growth factor in epithelial cells. J. Cell Biol. 121:145-154.
38. Yamashita, J.-i., M. Ogawa, S.-i. Yamashita, K. Nomura, M. Kuramoto, T. Saishoji, and S. Shin. 1994. Immunoreactive hepatocyle growth factor is a strong and independent predictor of recurrence and survival in human breast cancer. Cancer Res. 54:1630-1633.
39. Yayon, A., M. Klagsburg, J.D. Esko, P. Leder, and D.M. Ornitz. 1991. Cell surface heparin-like molecules are required for binding of bFGF to its high affinity receptor. Cell. 64:841-848.
40. Yoshinaga, Y., Y. Matsuno, S. Fujita, T. Nakamura, M. Kikuchi, Y. Shimosato, and S. Hirohashi. 1993. Immunohistochemical detection of hepatocyte growth factor/scatter factor in human cancerous and inflammatory lesions of various organs. Jpn. J. Canter Res. 84:1150-1158.
41. Zioncheck, T.F., L. Richardson, J. Liu, L. Chang, K.L. King, G. L. Bennett, P. Fugedi, S.M. Chamow, R.H. Schwall, and R.J. Stack. 1995. Sulfated oligosaccharides promote hepatocyte growth factor association and govern its milogenic activity. J. Biol. Chem. 270:16871-16878.